Back to search

Netherlands· NL-46c49ed9e18d

Ciclopiroxolamine ERC 10 mg/g, hydrofiele crème

A ciclopirox product containing ciclopiroxolamine, registered in Netherlands by Euro Registratie Collectief B.V.. The same ATC class is registered in 12 of our 19 countries.

ATC D01AE14

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCiclopiroxolamine ERC 10 mg/g, hydrof…ATCD01AE14REGISTER NO.NL-46c49ed9e18dPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Ciclopirox is registered in 12 of 19 countries.

Countries holding a registration under ATC D01AE14 (ciclopirox), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Ciclopirox · ATC D01AE14

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ciclopirox costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from <$0.001 in Czechia to $2.04 in Switzerland — a ×4085 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Ciclopirox · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.04
  • CZ Czechia<$0.001
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CICLOPIROXOLAMINE
Manufacturer
Euro Registratie Collectief B.V.
Country
Netherlands (NL)
ATC code
D01AE14
ATC class
Ciclopirox
Defined daily dose
20 mg, T
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    128910//15466

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

118 interactions on record for ciclopirox.

Graded by severity as the source publishes them — 118 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ciclopirox · interactions on record

118 records

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Ciclopirox in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ciclopirox products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Ciclocutan, Kitonail
  • Belgium · Myconail, Mycosten
  • Bulgaria · Батрафен, Микодефен
  • Cyprus · Kitonail, Mycomycen
  • Czechia · Polinail
  • Germany · Ciclocutan, Ciclopirox Acis
  • Denmark · Onytec
  • Estonia · Ciclopirox Auxilia
  • Spain · Ciclochem Uñas, Ciclocutan
  • Finland · Onytec
  • France · Ciclopirox Biogaran, Ciclopirox Substipharm
  • United Kingdom (Northern Ireland) · Onytec
  • Greece · Mycomycen
  • Croatia · Oxolam
  • Hungary · Batrafen, Kitolak
  • Ireland · Onytec
  • Italy · Carediesse, Niogermox
  • Lithuania · Onytec
  • Luxembourg · Mycoster
  • Latvia · Onytec
  • Norway · Onytec
  • Poland · Axopirox, Ciclolack
  • Portugal · Dexulac, Mycoster
  • Romania · Kitonail
  • Sweden · Onytec
  • Slovenia · Onytec
  • Slovakia · Polinaill

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2886c2f1-6af8-4b09-bebb-29044621487b
GET /v1/drugs/2886c2f1-6af8-4b09-bebb-29044621487b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Crème",
  "route": "Cutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h15466_smpc.pdf",
  "strength": null,
  "atc_label": "Ciclopirox",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg128910",
  "excipients": [
    "BENZYLALCOHOL (E 1519)",
    "CETYLALCOHOL",
    "MELKZUUR (L-,+ VORM) (E 270)",
    "MYRISTYLALCOHOL",
    "OCTYLDODECANOL",
    "PARAFFINE, DUNVLOEIBAAR (E 905)",
    "POLYSORBAAT 60 (E 435)",
    "SORBITANMONOSTEARAAT (E 491)",
    "STEARYLALCOHOL",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "CICLOPIROXOLAMINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h128910.pdf",
  "authorised_at": "2021/12/29",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "128910//15466",
  "additional_monitoring": "N"
}

See everything about ciclopirox.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.